Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Myeloid-mesenchymal crosstalk drives ARG1-dependent profibrotic metabolism via ornithine in lung fibrosis
Preeti Yadav, Javier Gómez Ortega, Prerna Dabral, Whitney Tamaki, Charles Chien, Kai-Chun Chang, Nivedita Biswas, Sixuan Pan, Julia Nilsson, Xiaoyang Yin, Aritra Bhattacharyya, Kaveh Boostanpour, Tanay Jujaray, Jasper T. Wang, Tatsuya Tsukui, Christopher J. Molina, Vincent C. Auyeung, Dean Sheppard, Baosheng Li, Mazharul Maishan, Hiroki Taenaka, Michael A. Matthay, Rieko Muramatsu, Lenka Maliskova, Arnab Ghosh, Walter L. Eckalbar, Ari B. Molofsky, Stanley J. Tamaki, Trever G. Bivona, Adam R. Abate, Allon Wagner, Satish K. Pillai, Paul J. Wolters, Kevin M. Tharp, Mallar Bhattacharya
Preeti Yadav, Javier Gómez Ortega, Prerna Dabral, Whitney Tamaki, Charles Chien, Kai-Chun Chang, Nivedita Biswas, Sixuan Pan, Julia Nilsson, Xiaoyang Yin, Aritra Bhattacharyya, Kaveh Boostanpour, Tanay Jujaray, Jasper T. Wang, Tatsuya Tsukui, Christopher J. Molina, Vincent C. Auyeung, Dean Sheppard, Baosheng Li, Mazharul Maishan, Hiroki Taenaka, Michael A. Matthay, Rieko Muramatsu, Lenka Maliskova, Arnab Ghosh, Walter L. Eckalbar, Ari B. Molofsky, Stanley J. Tamaki, Trever G. Bivona, Adam R. Abate, Allon Wagner, Satish K. Pillai, Paul J. Wolters, Kevin M. Tharp, Mallar Bhattacharya
View: Text | PDF
Research Article Immunology Pulmonology

Myeloid-mesenchymal crosstalk drives ARG1-dependent profibrotic metabolism via ornithine in lung fibrosis

  • Text
  • PDF
Abstract

Idiopathic pulmonary fibrosis (IPF) is a disease of progressive lung remodeling and collagen deposition that leads to respiratory failure. Myeloid cells are abundant in IPF lung and in murine lung fibrosis, but their functional effects are incompletely understood. Using mouse and human lung models, we show that ornithine produced by myeloid cells expressing arginase 1 (ARG1) serves as a substrate for proline and collagen synthesis by lung fibroblasts. The predominant ARG1-expressing myeloid cells in mouse lung were macrophages, but in IPF lung, high-dimensional imaging revealed ARG1 was expressed mainly in neutrophils. Small-molecule ARG1 inhibition suppressed both ornithine levels and collagen expression in cultured, precision-cut IPF lung slices and in murine lung fibrosis. These results were confirmed in macrophage-specific Arg1-KO mice. Furthermore, we found that this pathway is regulated by cell-to-cell crosstalk, starting with purinergic signaling: extracellular ATP receptor P2RX4 was necessary for fibroblast IL-6 expression, which, in turn, was necessary for ARG1 expression by myeloid cells. Taken together, our findings define an immune-mesenchymal circuit that governs profibrotic metabolism in lung fibrosis.

Authors

Preeti Yadav, Javier Gómez Ortega, Prerna Dabral, Whitney Tamaki, Charles Chien, Kai-Chun Chang, Nivedita Biswas, Sixuan Pan, Julia Nilsson, Xiaoyang Yin, Aritra Bhattacharyya, Kaveh Boostanpour, Tanay Jujaray, Jasper T. Wang, Tatsuya Tsukui, Christopher J. Molina, Vincent C. Auyeung, Dean Sheppard, Baosheng Li, Mazharul Maishan, Hiroki Taenaka, Michael A. Matthay, Rieko Muramatsu, Lenka Maliskova, Arnab Ghosh, Walter L. Eckalbar, Ari B. Molofsky, Stanley J. Tamaki, Trever G. Bivona, Adam R. Abate, Allon Wagner, Satish K. Pillai, Paul J. Wolters, Kevin M. Tharp, Mallar Bhattacharya

×

Figure 6

P2RX4 is necessary for IL-6 expression in mouse and human lung fibroblasts.

Options: View larger image (or click on image) Download as PowerPoint
P2RX4 is necessary for IL-6 expression in mouse and human lung fibroblas...
(A) Top left: UMAP plot of scRNA-Seq for macrophage-fibroblast cocultures with SingleR-based cell type annotation (2) shown. Data represent 2 separate cultures for each condition. Top right: UMAP plot for data showing sample of origin. Fib, fibroblast monoculture; Fib + Mac, fibroblast coculture with macrophages. Bottom left: Feature plot showing Il6 expression. Bottom right: Violin plot of Il6 expression. ***P < 0.001 by Wilcoxon’s rank-sum test corrected for multiple comparisons by Bonferroni’s method. (B) Gene set enrichment analysis of fibroblast single cell transcriptomes in coculture with macrophages compared with fibroblast monoculture using Gene Ontology “Response to stimulus” pathways. (C) IL-6 ELISA of conditioned media from macrophage-fibroblast cocultures with or without fibroblast-specific P2rx4 deletion. n = 5 biological replicates per condition. ****P < 0.0001 by 1-way ANOVA with post hoc Šídák’s multiple-comparison test. Data presented as mean ± SEM. (D) IL-6 ELISA of conditioned media from monocultured mouse lung fibroblasts from WT mice, with and without ATPγS and SB203580 (p38 MAP kinase inhibitor) treatment, or from fibroblast-specific P2rx4-KO (Pdgfrb-Cre P2rx4fl/fl) mice with ATPγS treatment. n = 8, 8, 5, and 3 biological replicates per respective condition. *P < 0.05, ***P < 0.001, ****P < 0.0001 by 1-way ANOVA with post hoc Šídák’s multiple-comparison test. (E) IL-6 ELISA of BAL from mice with or without fibroblast-specific P2rx4 deletion. n = 7, 7, and 6 biological replicates, respectively, left to right. *P < 0.05, **P < 0.01 by 1-way ANOVA with post hoc Šídák’s multiple-comparison test. (F) Left: IL-6 ELISA of conditioned media from human donor lung fibroblast monocultures with P2RX4 siRNA KD or nontargeting control siRNA (NT siRNA), with and without ATPγS treatment (left, n = 3 per condition). ***P < 0.001, ****P < 0.0001 by 1-way ANOVA with post hoc Šídák’s multiple-comparison test. Right: Quantification of KD by qPCR, n = 3 per condition. ***P < 0.001 by Student’s t test. (G) IL-6 ELISA of conditioned media from human donor lung fibroblast monocultures, human blood–derived neutrophil monocultures, or cocultures with or without P2RX4 inhibition with BAY-1797. Conditioned media were collected after 24 hours of culture. Each point represents a separate technical replicate. Neutrophils were derived from 2 separate blood donors, and fibroblasts were derived from 2 separate healthy lung donors. ***P < 0.001, ****P < 0.0001 by 2-way ANOVA followed by Šídák’s multiple-comparison test. Donor 1 and donor 2 represent separate donors for both neutrophils and fibroblasts. (C–F) Data are reported as mean ± SEM.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts